期刊文献+

甲状腺癌诊治现状医学伦理学思考 被引量:5

The Medical Ethics Ponder of Diagnosis and Treatment of Thyroid Cancer in the Present Situation
下载PDF
导出
摘要 随着经济的发展、健康意识的普及、超声技术的不断发展,甲状腺癌的发病率显著升高,新增的患者大多是对健康影响极低的甲状腺乳头状癌。正确认识,适度诊断、治疗是临床工作的重点。本文从"以人为本,尊重患者知情权,最小损伤,最大获益"医学伦理学的角度对甲状腺癌诊治领域的一些问题进行探讨,以达到技术判断与伦理判断的高度统一的医学伦理学追求,最终达到善待生命、善待患者、善待社会的目的。甲状腺癌的管理需要多学科共同完成,包括内分泌、外科、核医学、放射科、心理学、肿瘤科遗传学,从伦理学角度出发,在各学科中达到共识。 Thyroid cancer increase has been associated to socioeconomic status, better access to healthcare and rising use of thyroid imaging. Therefore, the rise could be apparent because of the useless identification of a large reservoir of subclinical papillary lesions that will never affect patient health. The correct understanding, appropriate diagnosis and fit treatment, are the key point for managing these patients successfully is the emphasis of clinical work. Some problems are discussed in the field of thyroid cancer from the point of hodegetics that people oriented, respect the right to know, the minimum damage and minimum benefit. Medical ethics is in pursuit of the highly unified judgement of technique and ethical, and reaeh the finally destination of being kind to life, patients and society. Managing thyroid cancer requires the involvement of multiple subspecialties that may include endocrinology, surgery, nuclear medicine, radiology, medical oneology, and genetic counseling.
出处 《医学与哲学(B)》 2015年第9期85-87,共3页 Medicine & Philosophy(B)
关键词 甲状腺癌 医学伦理学 知情权 thyroid cancer, hodegetics, the right to know
  • 相关文献

参考文献19

  • 1Lee J H,Shin S W. Overdiagnosis and screening for thyroid cancer in Korea[J]. I.ancet,2014,384(9957) :1848-1852.
  • 2Davies L,Welch H G. Increasing incidence of thyroid cancer in the United States,1973-2002[J].JAMA,2006,295(18):2164-2167.
  • 3孙嘉伟,许晓君,蔡秋茂,许燕君,顾江.中国甲状腺癌发病趋势分析[J].中国肿瘤,2013,22(9):690-693. 被引量:210
  • 4Rahib L,Smith B D, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States[J]. Cancer Res, 2014,74 (8) : 2913-2921.
  • 5Ito Y, Miyauchi A. Nonoperative management of low-risk differenti- ated thyroid carcinoma[J]. Curr Opin Oneol,2015,27(1) : 15-20.
  • 6Schlumberger M, Paeini F, Wiersinga W M, et al. Follow-up and man agement of differentiated thyroid carcinoma: a European perspective in clinical practice[J]. Eur J Endocrinol, 2004,151 (5) : 539 - 548.
  • 7Jonkl J,Sarlis N J, Litofsky D, et al. Outcomes of patients with dif ferentiated thyroid carcinoma following initial therapy[J]. Thyroid, 2006,16(1) :1229-1234.
  • 8Sawka A M,Goldstein D P,Brierley J D, et al. The impact of thy- roid cancer and post- surgical radioactive iodine treatment on the lives of thyroid cancer survivors:a qualitative study[J]. PLoS One,2009,4(1) :4191-4195.
  • 9Mihailovic J, Stefanovic L, Stankovic R. Influence of initial treat ment on the survival and recurrence in patients with differentiated thyroid microcarcinoma[J]. Clin Nucl Med, 2013,38 ( 3 ) : 332- 338.
  • 10McLeod D S, Sawka A M, Cooper D S. Controversies in primary treatment of love risk papillary thyroid cancer[J]. Lancet, 2013,381 (12) : 1046- 1051.

二级参考文献29

  • 1Sherman SI. Thyroid carcinoma[J]. Lancet, 2003,361:501-511.
  • 2Cooper D S,Doherty G M, Haugen B R, et al. Manegement guidelines for petients with thyroid nodules and differentiated thyroider[J]. Thyroid, 2006,16:1 - 33.
  • 3Baloeh Z W,LiVolsi V A,Asa S L, et al. Diagnostic terminology and morphologie criteria for cytologic diagnosis of thyroid lesion: a synopsis of the National Cancer Iustitute Thyroid Fine-Needle Aspiration state of the science conference[J]. Diagn cytopathol, 2008,36: 425- 437.
  • 4Kim E,Park J S,Son K R,et al. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma : comparison of ultrasound, computed tomography and combined ultrasound with computed tomography[J]. Thyroid,2008,18:411-418.
  • 5Mitchell J C,Grant F,Evenson A R,et al. Preoperative evaluation of thyroid nodules with 18 FDG--PET--CT[J]. Surgery, 2005,138 : 1166 - 1174.
  • 6Nix P, Nicolaides A, coatesworth A P. Thyroid cancer review: presentation and investigation of thyroid cancer[J]. Int J clin praet, 2005,59: 1459-1463.
  • 7Davies L, Welch H G. Increasing of thyroid cancer in The United States, 1973 - 2002 [J]. JAMA, 2006,295: 2164 - 2167.
  • 8Kupferman M E,Weinstock Y E,Santillan A A,et al. Predictors of level V metastasis in well differentiated thyroid cancer[J]. Head Neck,2008,30(11): 1469-1474.
  • 9Byers R M,Wolf P F, Ballantyne A J. Rationale for elective modi lied neck dissection[J]. Head Neck Surg, 1988,10(3): 160- 167.
  • 10Caron N R, Tan Y Y, Ogilivie J B, et al. Selective modified radical neck dissection for papillary thyroid cancer is level I,II and V dis section alwaysnecessary[J].WorldJ Surg,2006,30(5):833-840.

共引文献220

同被引文献36

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部